Figure 5.
Proposed model of miR-29a-relayed pathway in the treatment of cholestasis. Exogenous miR-29a ameliorates cholestasis-induced proteotoxic stress, hepatitis, and liver fibrosis by suppressing PI3K85α.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.